Furthermore, proinflammatory cytokines including CXCL9, TNF-α, CCL4, and CCL3 were also upregulated in the tumor following the combined therapy, further demonstrating the change in the immune environment (Additional file 1: Figure S18A–I). This evidence concerns the gene CXCL9 and neoplasm.